227 related articles for article (PubMed ID: 29674325)
1. ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).
Rautureau Y; Deschambault V; Higgins MÈ; Rivas D; Mecteau M; Geoffroy P; Miquel G; Uy K; Sanchez R; Lavoie V; Brand G; Nault A; Williams PM; Suarez ML; Merlet N; Lapointe L; Duquette N; Gillis MA; Samami S; Mayer G; Pouliot P; Raignault A; Maafi F; Brodeur MR; Levesque S; Guertin MC; Dubé MP; Thorin É; Rhainds D; Rhéaume É; Tardif JC
Circulation; 2018 Oct; 138(16):1677-1692. PubMed ID: 29674325
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
[TBL] [Abstract][Full Text] [Related]
3. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
[TBL] [Abstract][Full Text] [Related]
4. Endothelial-Specific Overexpression of Histone Deacetylase 2 Protects Mice against Endothelial Dysfunction and Atherosclerosis.
Hori D; Nomura Y; Nakano M; Han M; Bhatta A; Chen K; Akiyoshi K; Pandey D
Cell Physiol Biochem; 2020 Sep; 54(5):947-958. PubMed ID: 32975918
[TBL] [Abstract][Full Text] [Related]
5. Adcy9 Gene Inactivation Improves Cardiac Function After Myocardial Infarction in Mice.
Ferron M; Merlet N; Mihalache-Avram T; Mecteau M; Brand G; Gillis MA; Shi Y; Nozza A; Cossette M; Guertin MC; Rhéaume E; Tardif JC
Can J Cardiol; 2023 Jul; 39(7):952-962. PubMed ID: 37054880
[TBL] [Abstract][Full Text] [Related]
6. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
[TBL] [Abstract][Full Text] [Related]
7. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
8. Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.
Vozenilek AE; Vetkoetter M; Green JM; Shen X; Traylor JG; Klein RL; Orr AW; Woolard MD; Krzywanski DM
J Vasc Res; 2018; 55(2):98-110. PubMed ID: 29455203
[TBL] [Abstract][Full Text] [Related]
9. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
Harder C; Lau P; Meng A; Whitman SC; McPherson R
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
[TBL] [Abstract][Full Text] [Related]
12. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
Roche-Molina M; Sanz-Rosa D; Cruz FM; García-Prieto J; López S; Abia R; Muriana FJ; Fuster V; Ibáñez B; Bernal JA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):50-9. PubMed ID: 25341796
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis.
Vozenilek AE; Navratil AR; Green JM; Coleman DT; Blackburn CMR; Finney AC; Pearson BH; Chrast R; Finck BN; Klein RL; Orr AW; Woolard MD
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):324-334. PubMed ID: 29217509
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 deficiency attenuated atherogenesis and decreased macrophage infiltration by targeting Dusp-8.
Gao L; Zeng H; Zhang T; Mao C; Wang Y; Han Z; Chen K; Zhang J; Fan Y; Gu J; Wang C
Atherosclerosis; 2019 Dec; 291():78-86. PubMed ID: 31704554
[TBL] [Abstract][Full Text] [Related]
15. Danhong Injection Attenuates High-Fat-Induced Atherosclerosis and Macrophage Lipid Accumulation by Regulating the PI3K/AKT Insulin Pathway.
Zhou M; Ren P; Li S; Kang Q; Zhang Y; Liu W; Shang J; Gong Y; Liu H
J Cardiovasc Pharmacol; 2019 Aug; 74(2):152-161. PubMed ID: 31306371
[TBL] [Abstract][Full Text] [Related]
16. Roles for endothelial cell and macrophage Gch1 and tetrahydrobiopterin in atherosclerosis progression.
Douglas G; Hale AB; Patel J; Chuaiphichai S; Al Haj Zen A; Rashbrook VS; Trelfa L; Crabtree MJ; McNeill E; Channon KM
Cardiovasc Res; 2018 Aug; 114(10):1385-1399. PubMed ID: 29596571
[TBL] [Abstract][Full Text] [Related]
17. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
[TBL] [Abstract][Full Text] [Related]
18. Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in atheroprotection.
Rautureau Y; Berlatie M; Rivas D; Uy K; Blanchette A; Miquel G; Higgins MÈ; Mecteau M; Nault A; Villeneuve L; Lavoie V; Théberge-Julien G; Brand G; Lapointe L; Denis M; Rosa C; Fortier A; Blondeau L; Guertin MC; Dubé MP; Thorin É; Ledoux J; Rhainds D; Rhéaume É; Tardif JC
Cardiovasc Res; 2023 Mar; 119(2):450-464. PubMed ID: 35576489
[TBL] [Abstract][Full Text] [Related]
19. Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.
Rhainds D; Packard CJ; Brodeur MR; Niesor EJ; Sacks FM; Jukema JW; Wright RS; Waters DD; Heinonen T; Black DM; Laghrissi-Thode F; Dubé MP; Pfeffer MA; Tardif JC
Circ Genom Precis Med; 2021 Apr; 14(2):e003219. PubMed ID: 33794646
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
